Metrogel 1%

Long considered to be the main standard topical treatment for rosacea, Metrogel 1% is the Galderma branded treatment that contains 1% of Metronidazole. Over the years Galderma has brought us Metrogel 0.75%, Metrolotion, Metrocream and now Metrogel 1% Pump 55gm.
Be sure to check out the Metrogel 1% User Reviews and How does Metrogel work?.

Recent Rosacea Blog Posts

Generic Metrogel Pump 1% from Sandoz

Despite suggestions that Generic Metrogel is easily available in the US, there are scant reports online from users getting access to cheaper Metronidazole 1% treatments. In July this year Sandoz announced that they were selling a generic version of Metrogel 1%. The generic versions of metronidazole gel were previously restricted to 0.75% as the patent […]

Continue Reading

Ivermectin better than Metrogel 0.75% for papules and pustules

Some just published research from the Ivermectin Phase III study group suggests that Ivermectin 1% cream once a day is better than Metronidazole 0.75% twice a day at treating the papules and pustules of rosacea. The British Journal of Dermatology paper tells us that although both Ivermectin and Metronidazole did lead to a reduction in […]

Continue Reading

The National Rosacea Society is 20 Years Old

A recent blog posting from the NRS has mentioned that this month the National Rosacea Society is 20 years old. NRS Celebrates 20 Years Thursday, September 6, 2012 The National Rosacea Society (NRS) marks its 20th anniversary in 2012, and is pleased to report on the vast ongoing progress that has been made toward fulfilling […]

Continue Reading

Acne seems to have a lot of available treatments. Certainly compared to rosacea, acne has a bigger array of possible treatments that have been proven to be viable treatments. One of the interesting things about rosacea is that even though it can look like acne for some, generally it cannot be treated by otherwise helpful […]

Continue Reading

Novartis Must Drop Fougera’s Generic Metrogel

In May this year we learnt that Novartis would be buying Fougera Pharmaceuticals . One of the products that would come over to Novartis through this deal would be generic metronidazole. Today the FTC has approved the $1.5b deal, but has ruled that Novartis must relinquish Fougera’s rights to manufacturer generic metronidazole, and leave the […]

Continue Reading

 

Top

Subscribe to Rosacea News

Enter your email address to receive the latest news about rosacea in your inbox.